BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3114483)

  • 1. Alveolar macrophage gold retention in rheumatoid arthritis.
    Garcia JG; Munim A; Nugent KM; Bishop M; Hoie-Garcia P; Parhami N; Keogh BA
    J Rheumatol; 1987 Jun; 14(3):435-8. PubMed ID: 3114483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse pulmonary injury associated with gold treatment.
    Winterbauer RH; Wilske KR; Wheelis RF
    N Engl J Med; 1976 Apr; 294(17):919-21. PubMed ID: 130554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinopeptide A reactive peptides and procoagulant activity in bronchoalveolar lavage: relationship to rheumatoid interstitial lung disease.
    Idell S; Garcia JG; Gonzalez K; McLarty J; Fair DS
    J Rheumatol; 1989 May; 16(5):592-8. PubMed ID: 2666653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Pulmonary reaction to chrysotherapy.
    N Engl J Med; 1976 Aug; 295(9):506-7. PubMed ID: 820998
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of gold-induced pneumonitis showing a positive reaction in the drug lymphocyte stimulation test (DLST) for gold].
    Bando M; Takishita Y; Bando H; Hashimoto Y; Sano T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):128-32. PubMed ID: 1625388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold pneumonitis. A case report with electronmicroscopy and electron probe analysis.
    Lertratanakul Y; Budiman-Mak E; Dietz AA; Jablokow VR; Rothfuss S; Schumacher HR
    Clin Exp Rheumatol; 1986; 4(4):371-4. PubMed ID: 3098485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case report and literature analysis of the clinical factors relating to the development of fibrotic changes in gold lung].
    Aoshiba K; Fukuda I; Mochizuki M; Tamaoki J; Konno K; Takizawa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):336-43. PubMed ID: 2113147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T-lymphocytosis and lymphokines in bronchoalveolar lavage fluid of a gold salt-induced pneumonitis].
    Ikeda S; Chikazawa C; Naoe H; Manba K; Yasuda K; Yastake T; Honda M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Nov; 24(11):1258-65. PubMed ID: 3104641
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of gold lung with positive lymphocyte stimulation test to gold, using bronchoalveolar lymphocytes].
    Matsumura Y; Miyake A; Ishida T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Mar; 30(3):472-7. PubMed ID: 1569728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse pulmonary injury associated with gold treatment.
    Nickels J; van Assendelft AH; Tukiainen P
    Acta Pathol Microbiol Immunol Scand A; 1983 Jul; 91(4):265-7. PubMed ID: 6408886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gold salt alveolitis in 3 patients with rheumatoid arthritis].
    Music E; Tomsic M; Logar D
    Pneumologie; 1995 Jun; 49(6):367-72. PubMed ID: 7644457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concentration of gold in macrophages of the bone marrow in rheumatic diseases subjected to chrysotherapy].
    Galle P; Villiaumey J
    Rev Rhum Mal Osteoartic; 1982 Mar; 49(4):273-9. PubMed ID: 7089467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs.
    Scherak O; Popp W; Kolarz G; Wottawa A; Ritschka L; Braun O
    J Rheumatol; 1993 Jun; 20(6):944-9. PubMed ID: 8102405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary gold toxicity.
    Morley TF; Komansky HJ; Adelizzi RA; Giudice JC
    Eur J Respir Dis; 1984 Nov; 65(8):627-32. PubMed ID: 6440806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver dysfunction associated with gold therapy for rheumatoid arthritis.
    Edelman J; Donnelly R; Graham DN; Percy JS
    J Rheumatol; 1983 Jun; 10(3):510-1. PubMed ID: 6411922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fatal pulmonary fibrosis caused by gold therapy?].
    Chatzigiannis I; Schmidt KL; Stambolis C
    Z Rheumatol; 1984; 43(2):49-58. PubMed ID: 6428074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chrysotherapy: a synoptic review.
    Eisler R
    Inflamm Res; 2003 Dec; 52(12):487-501. PubMed ID: 14991077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cigarette smoking on blood gold distribution during chrysotherapy.
    James DW; Ludvigsen NW; Cleland LG; Milazzo SC
    J Rheumatol; 1982; 9(4):532-5. PubMed ID: 6813469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
    Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chrysotherapy-induced aplastic anemia: a case report.
    Shearer CA; Parker WA
    Am J Hosp Pharm; 1978 Sep; 35(9):1095-9. PubMed ID: 100010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.